Mark Shlomchik, MD, PhD
Co-Founder and Chief Scientific Officer
Mark Shlomchik received MD and PhD degrees from the University of Pennsylvania and did his residency in Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania.
He was appointed to the faculty of Yale University School of Medicine in 1993, where he remained until 2013 when he moved to the University of Pittsburgh to become the UPMC Endowed Professor and Chair of the Department of Immunology.
Dr Shlomchik is known for his world-leading research in systemic autoimmune diseases and B cell immune responses and memory. He has published over 160 original research and 30 review articles. The TCXpress™ technology originated and was developed in Dr Shlomchik’s lab.